ICU侵袭性念珠菌病患者连续(1,3)-β-D-葡聚糖测定的预后价值
意大利ICU十年观察性队列研究纳入103例确诊侵袭性念珠菌病且至少2次BDG测定的患者,其中68例血流感染、35例腹腔感染。54例BDG随时间下降(BDG下降组),49例未下降(N-BDG下降组);BDG下降组侵袭性念珠菌病相关病死率低于N-BDG下降组(17% vs 53%,p<0.01)。多因素Cox回归显示感染发生时脓毒性休克(HR 3.24,95%CI 1.25-8.44,p=0.02)和慢性肝病(HR 7.27,95%CI 2.33-22.66,p<0.01)与病死率相关,而BDG下降是唯一的生存预测因素(HR 0.19,95%CI 0.09-0.43,p<0.01)。BDG下降预测良好临床结局的ROC曲线下面积为0.74(p=0.02),BDG降幅>70%预测生存的特异度和阳性预测值均为100%。
要点
- 103例ICU确诊侵袭性念珠菌病患者中,BDG下降组侵袭性念珠菌病相关病死率低于N-BDG下降组(17% vs 53%,p<0.01)。
- 多因素Cox回归中BDG下降是唯一的生存预测因素(HR 0.19,95%CI 0.09-0.43,p<0.01)。
- 感染发生时脓毒性休克(HR 3.24,95%CI 1.25-8.44,p=0.02)和慢性肝病(HR 7.27,95%CI 2.33-22.66,p<0.01)与侵袭性念珠菌病病死率相关。
- BDG下降预测良好临床结局的ROC曲线下面积为0.74(p=0.02)。
- BDG降幅>70%预测生存的特异度和阳性预测值均为100%。
适用人群与场景
- 意大利ICU患者,研究期2012-2022年,确诊侵袭性念珠菌病且至少有2次BDG测定。
- 研究人群103例,年龄47(35-62)岁,SAPS II评分67(52-77);68例血流感染、35例腹腔感染。
诊断标准与关键阈值
- 确诊侵袭性念珠菌病且至少2次BDG测定。
- BDG降幅>70%预测生存,特异度和阳性预测值均为100%。
红旗征与不能漏的情况
- 感染发生时脓毒性休克与侵袭性念珠菌病病死率相关(HR 3.24,95%CI 1.25-8.44,p=0.02)。
- 慢性肝病与侵袭性念珠菌病病死率相关(HR 7.27,95%CI 2.33-22.66,p<0.01)。
研究设计与关键结果
- 观察性队列研究,103例ICU确诊侵袭性念珠菌病患者,54例BDG随时间下降(BDG下降组)、49例未下降(N-BDG下降组)。
- 病原体以白色念珠菌最常见(61%),其次为近平滑念珠菌(17%)和光滑念珠菌(12%),组间无差异。
- 侵袭性念珠菌病相关病死率BDG下降组17% vs N-BDG下降组53%(p<0.01)。
- 多因素Cox回归:感染发生时脓毒性休克HR 3.24(95%CI 1.25-8.44)p=0.02;慢性肝病HR 7.27(95%CI 2.33-22.66)p<0.01;BDG下降HR 0.19(95%CI 0.09-0.43)p<0.01。
- BDG下降预测良好临床结局的ROC曲线下面积0.74(p=0.02);BDG降幅>70%预测生存的特异度和阳性预测值均为100%。
证据类型、等级与局限
- 证据类型:观察性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 在ICU确诊侵袭性念珠菌病患者中,连续监测BDG下降可能有助于判断预后,BDG降幅>70%预测生存的特异度和阳性预测值均为100%。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: To determine whether a decrease in serum (1,3)-β-D-glucan (BDG) was associated with reduced mortality and to investigate the performance of BDG downslope in predicting clinical outcome in invasive candidiasis.
METHODS: Observational cohort study in ICU patients over a ten-year period (2012-2022) in Italy. Proven invasive candidiasis with at least 2 BDG determinations were considered.
RESULTS: In the study population of 103 patients (age 47 [35-62] years, SAPS II score 67 [52-77]) 68 bloodstream and 35 intrabdominal infections were recorded. Serial measurements showed that in 54 patients BDG decreased over time (BDG downslope group) while in 49 did not (N-BDG downslope group). Candida albicans was the pathogen most frequently isolated (61%) followed by C. parapsilosis (17%) and C. glabrata (12%), in absence of any inter-group difference. Invasive candidiasis related mortality was lower in BDG downslope than in N-BDG downslope group (17% vs 53%, p < 0.01). The multivariate Cox regression analysis showed the association of septic shock at infection occurrence and chronic liver disease with invasive candidiasis mortality (HR [95% CI] 3.24 [1.25-8.44] p = 0.02 and 7.27 [2.33-22.66] p < 0.01, respectively) while a BDG downslope was the only predictor of survival (HR [95% CI] 0.19 [0.09-0.43] p < 0.01). The area under the receiver operator characteristic curve for the performance of BDG downslope as predictor of good clinical outcome was 0.74 (p = 0.02) and our model showed that a BDG downslope > 70% predicted survival with both specificity and positive predictive value of 100%.
CONCLUSIONS: A decrease in serum BDG was associated with reduced mortality and a steep downslope predicted survival with high specificity in invasive candidiasis.
参考来源
- Carelli S, Posteraro B, Torelli R, et al. Prognostic value of serial (1,3)-β-D-glucan measurements in ICU patients with invasive candidiasis. Crit Care. 2024. PMID: 38997712. doi:10.1186/s13054-024-05022-x
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。